New pathway for mRNA drug delivery shows shape of things to come

New pathway for mRNA drug delivery shows shape of things to come

Scientists have discovered that the internal shape of tiny drug-delivery particles – called lipid nanoparticles – has a big impact on how well our cells absorb them, paving the way to more efficient vaccine and drug delivery.

The RMIT University and Osaka University study published in top journal Small is the first to reveal that certain lipid nanoparticle shapes are absorbed by cells up to eight times better than others, with significant implications for mRNA gene therapy design. 

Lipid nanoparticles have emerged as critical platforms for drug and gene delivery, with the success of mRNA COVID-19 vaccines highlighting their potential. 

Yet our understanding of how to deliver these mRNA gene therapies to target cells more efficiently remains limited, explained study first author Sue Lyn Yap.

“One of the major challenges in nanomedicine is that most nanoparticles are taken up by cells through pathways that trap and degrade them, with studies showing less than 2% of gene therapies successfully reach their target inside the cell,” said Yap, who is in the final stages of her PhD at RMIT University in Australia. 

Sue Lyn Yap led the study as part of her PhD at RMIT University. Sue Lyn Yap led the study as part of her PhD at RMIT University.

These nanoparticles have different internal structures such as layers (liposomes) or more complex 3D cubic shapes (cubosomes), with researchers discovering that these shapes have a big impact on what pathways they take to enter cells.

Cubosomes are tiny nanoscale particles formulated from the self-assembly of lipids in water.

The lipids self-assemble into an intricate and complex 3D cubic structure, with water channels and lipid bridges running throughout the entire particle that can be used to package small molecule drugs.

A cubosome nanoparticle magnified more than 30,000 times, showing its lipids self-assembled into a cubic structure. A cubosome nanoparticle magnified more than 30,000 times, showing its lipids self-assembled into a cubic structure.

In vitro tests using an epithelial cell line found cubosomes were the most efficient at entering cells.

The study revealed cubosomes were eight times more likely to enter the cells than liposomes, which are what most lipid-based nanomedicines and commercial products use today.

This finding opens a new frontier in designing lipid nanoparticles to deliver drugs more efficiently.

Microscopy images showing the increased presence of cubosome material found in cells (right) as compared to the liposomes (left). The red represents the nanoparticle lipids, contrasted against the green cellular material. Microscopy images showing the increased presence of cubosome material found in cells (right) as compared to the liposomes (left). The red represents the nanoparticle lipids, contrasted against the green cellular material.

“What we found really interesting was that these particles don’t rely just on the usual active processes to enter cells, like endocytosis, where the cell swallows them,” Yap said. 

“We discovered that cubosomes can also enter cells through other more passive routes, such as fusing with the cell membrane directly, essentially sneaking past the cellular barriers that usually destroy them.

“Next, we aim to explore how these structured nanoparticles behave in the body and whether they can be tailored to target specific tissues or diseases more precisely,” she said.

Sue Lyn Yap in the RMIT labs. Sue Lyn Yap in the RMIT labs.

The groundbreaking collaboration was supervised by corresponding authors RMITs Distinguished Professor Calum Drummond AO, Professor Charlotte Conn and Dr Nhiem Tran in collaboration with researchers at Osaka University, Japan.

The research spread across multiple facilities including the Australian Synchrotron (ANSTO), the Micro Nano Research Facility (RMIT), the Molecular Assembly Lab (RMIT), the Ian Holmes Imaging Centre (Bio 21 Institute), and the Biophotonics Laboratory (Immunology Frontier Research Center at Osaka University).

‘The Internal Nanostructure of Lipid Nanoparticles Influences Their Diverse Cellular Uptake Pathways’ is published in Small (DOI:10.1002/smll.202500903).

To discuss collaboration, contact research.partnerships@rmt.edu.au

 

Story: Michael Quin

17 June 2025

Share

Return to RMIT News
17 June 2025

Share

  • Research
  • STEM
  • Nano & Microtechnology
  • Science and technology
Engage

Related News

MagdalenaClare.jpg

Blood test offers hope for more effective ovarian cancer treatment

Scientists have created a blood test to guide more effective ovarian cancer treatment, by identifying the women more likely to respond to an ovarian cancer treatment known as PARP inhibitor therapy.

RMIT leaders with HIPELKI Chairman.

MedTech at heart of Indonesia collaboration

RMIT’s expertise in medical technology (MedTech) is shaping new partnerships and initiatives designed to increase cooperation and collaboration in Indonesia’s healthcare sector.

RMIT_Bristile_tilesWEB.jpg

Low carbon roof tiles give industrial waste a new home

A large-scale trial of sustainable roof tiles by RMIT and Bristile Roofing has shown that incorporating coal ash and glass waste can reduce their carbon footprint.

Dr Baoyue Zhang and Dr Sanjida Afrin, wearing lab gowns, gloves and safety glasses, work together at a fume hood while handling laboratory pipettes.

Tiny metal particles show promise for targeted cancer treatments

An international research team led by RMIT University has created tiny particles, known as nanodots, made from a metallic compound that can kill cancer cells while leaving healthy cells largely unharmed.

Show more
aboriginal flag float-start torres strait flag float-start

Acknowledgement of Country

RMIT University acknowledges the people of the Woi wurrung and Boon wurrung language groups of the eastern Kulin Nation on whose unceded lands we conduct the business of the University. RMIT University respectfully acknowledges their Ancestors and Elders, past and present. RMIT also acknowledges the Traditional Custodians and their Ancestors of the lands and waters across Australia where we conduct our business - Artwork 'Sentient' by Hollie Johnson, Gunaikurnai and Monero Ngarigo.

More information